Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells

被引：30

作者：

Miyamoto, Daisei ^{[1
,2
,3
]}

Hasegawa, Sayaka ^{[2
,3
]}

Sriwilaijaroen, Nongluk ^{[4
,5
]}

Yingsakmongkon, Sangchai ^{[4
,6
]}

Hiramatsu, Hiroaki ^{[1
,4
]}

Takahashi, Tadanobu ^{[1
,2
,3
]}

Hidari, Kazuya ^{[1
,2
,3
]}

Guo, Chao-Tan ^{[1
,4
,7
]}

Sakano, Yuichi ^{[2
,8
]}

Suzuki, Takashi ^{[1
,2
,3
]}

Suzuki, Yasuo ^{[1
,3
,4
]}

机构：

[1] Univ Shizuoka, Sch Pharmaceut Sci, CREST JST, Shizuoka 4228526, Japan

[2] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan

[3] Univ Shizuoka, Sch Pharmaceut Sci, Global COE Program Innovat Human Hlth Sci, Shizuoka 4228526, Japan

[4] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Aichi 4878501, Japan

[5] Thammasat Univ, Fac Med, Pathum Thani 12120, Thailand

[6] Kasetsart Univ, Dept Microbiol & Immunol, Fac Vet Med, Bangkok 10900, Thailand

[7] Zhejiang Acad Med Sci, Hangzhou 310016, Peoples R China

[8] Japan Hlth Sci Fdn, Chuo Ku, Tokyo 1030001, Japan

来源：

BIOLOGICAL & PHARMACEUTICAL BULLETIN | 2008年 / 31卷 / 02期

关键词：

clarithromycin; influenza virus; anti-influenza drug;

D O I：

10.1248/bpb.31.217

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In vitro effects of macrolide clarithromycin (CAM) on influenza A virus-infected cells were examined using plaque reduction assay by treating cells either before or after viral adsorption. The significant inhibitory effect on influenza virus infection was detected only when the cells were treated with CAM after viral adsorption. The predominant inhibitory effect was observed during 4-7th hour after viral adsorption using viral production assay. CAM did not exhibit inhibitory effects on influenza virus hemagglutination, membrane fusion and viral sialidase activities. These findings indicate that CAM acts on a middle to late stage of the viral replication cycle resulting in inhibition of progeny virus production from the infected cells.

引用

页码：217 / 222

页数：6

共 37 条

[21] Influenza: old and new threats
Palese, P
[J]. NATURE MEDICINE, 2004, 10 (12) : S82 - S87
[22] The Japanese experience with vaccinating schoolchildren against influenza.
Reichert, TA
Sugaya, N
Fedson, DS
Glezen, WP
Simonsen, L
Tashiro, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) : 889 - 896
[23] Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice
Sato, K
Suga, M
Akaike, T
Fuji, S
Muranaka, H
Doi, T
Maeda, H
Ando, M
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) : 853 - 857
[24] Synthesis and biological investigation of new 4"-malonyl tethered derivatives of erythromycin and clarithromycin
Sherman, D
Xiong, LQ
Mankin, AS
Melman, A
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1506 - 1509
[25] Complications of influenza infection in children
Siberry, GK
[J]. PEDIATRIC ANNALS, 2000, 29 (11): : 683 - 690
[26] Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor
Sidwell, RW
Huffman, JH
Barnard, DL
Bailey, KW
Wong, MH
Morrison, A
Syndergaard, T
Kim, CU
[J]. ANTIVIRAL RESEARCH, 1998, 37 (02) : 107 - 120
[27] EFFICACY OF INACTIVATED VACCINE IN PREVENTING ANTIGENICALLY DRIFTED INFLUENZA TYPE-A AND WELL-MATCHED TYPE-B
SUGAYA, N
NEROME, K
ISHIDA, M
MATSUMOTO, M
MITAMURA, K
NIRASAWA, M
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (14): : 1122 - 1126
[28] SINGLE-AMINO-ACID SUBSTITUTION IN AN ANTIGENIC SITE OF INFLUENZA-VIRUS HEMAGGLUTININ CAN ALTER THE SPECIFICITY OF BINDING TO CELL MEMBRANE-ASSOCIATED GANGLIOSIDES
SUZUKI, Y
KATO, H
NAEVE, CW
WEBSTER, RG
[J]. JOURNAL OF VIROLOGY, 1989, 63 (10) : 4298 - 4302
[29] ISOLATION AND CHARACTERIZATION OF RECEPTOR SIALOGLYCOPROTEIN FOR HEMAGGLUTINATING VIRUS OF JAPAN (SENDAI VIRUS) FROM BOVINE ERYTHROCYTE-MEMBRANE
SUZUKI, Y
SUZUKI, T
MATSUMOTO, M
[J]. JOURNAL OF BIOCHEMISTRY, 1983, 93 (06) : 1621 - 1633
[30] SUZUKI Y, 1985, J BIOL CHEM, V260, P1362

← 1 2 3 4 →